Cancer Research UK

Caris Life Sciences study reports positive results for evidence-guided tumor profiling

Tuesday, October 1, 2013 10:00 AM

Caris Life Sciences, a biosciences company focused on personalized medicine, has announced data from two studies which demonstrate the potential of evidence-guided tumor profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) and rarer and refractory cancers.

More... »

Cancer Research Technology Pioneer fund, BACIT, Sareum ink agreement

Friday, September 27, 2013 11:18 AM

The Cancer Research Technology Pioneer Fund (CPF), Battle Against Cancer Investment Fund (BACIT) and drug discovery company Sareum, have entered into an agreement to co-fund the further development of a class of cancer drugs called CHK1 inhibitors.

More... »

Otsuka to acquire Astex Pharmaceuticals

Friday, September 6, 2013 03:00 PM

Otsuka Pharmaceuticals will acquire Astex Pharmaceuticals for approximately $886 million, through a tender offer for all outstanding Astex shares expected to close in the fourth quarter.

More... »

AstraZeneca inks cancer collaboration

Wednesday, July 10, 2013 12:27 PM

AstraZeneca has entered into an agreement with the University of Cambridge and Cancer Research U.K. for a two-year collaboration on three preclinical and clinical oncology projects. This agreement aims to advance cancer research through the study of tumor mutations and new investigational therapies in prostate, pancreatic and potentially other cancers.

More... »

ExpreS2ion Biotechnologies, Cancer Research U.K. enter license agreement

Monday, June 10, 2013 11:35 AM

ExpreS²ion Biotechnologies has signed a research license agreement to provide the Protein Purification Facility at Cancer Research U.K.’s London Research Institute with access to its Drosophila Schneider-2 cell-based technology platform—ExpreS²—for protein production.

More... »

Top technology gurus join to design mobile phone game to help speed cancer cures

Friday, March 1, 2013 02:30 PM

Cancer Research UK is bringing together its world-leading scientists with technology gurus such as Amazon Web Services, Facebook and Google to design and develop a mobile game to accelerate cures for cancer.

More... »

Genetically engineered virus extends lives of terminally-ill liver cancer patients

Wednesday, February 13, 2013 03:01 PM

A genetically-engineered virus has prolonged the lives of terminally ill liver cancer patients in a small clinical trial, according to the findings published in Nature Medicine. The results will need confirming in larger studies, but Cancer Research U.K. welcomed the advance as "an exciting step forward."

More... »

Cancer Research U.K. and Astex’s CRT initiate AT13148 trial for cancer

Friday, January 18, 2013 03:18 PM

Cancer Research Technology (CRT), the commercial arm of Astex Pharmaceuticals, a pharmaceutical company focused on novel small molecule therapeutics, along with its collaborator Cancer Research U.K., has initiated a trial of an experimental drug shown to simultaneously block many enzymes that control cancer cell growth and death.

More... »

CRT and ADC Therapeutics partner on antibody drug conjugates

Friday, July 6, 2012 03:02 PM

Cancer Research Technology (CRT), the commercial arm of Cancer Research U.K., and Switzerland-based ADC Therapeutics have signed agreements to develop cancer treatments called antibody drug conjugates (ADCs) using CRT antibodies and peptides and ADCT's “warhead” and linker chemistries.

More... »